moa of glp 1 agonists Recent updates on GLP-1 agonists: Current advancements & challenges The dual glucose-dependent insulinotropic polypeptide

The proposed mechanism as shown in Fig

Overview and recent advances in electrochemical sensing of glutathioneA review

doi: 10.1016/S0090-4295(98)00094-6

If improvement plateaus or symptoms persist despite treatment, further investigation may be warranted to identify other contributing factors or alternative diagnoses

A clinical trial investigated the effect of 8-week metformin treatment on aging individuals with mild cognitive impairment (MCI) or early AD, and the results revealed that metformin is associated with improved executive function, companied by improvement in learning/memory and attention [27]

This compound is not intended for human consumption, veterinary use, clinical research involving human subjects, therapeutic use, or diagnostic applications